Shire Targets Teva Over Generic Intuniv
Shire LLC has launched a patent infringement suit against Teva Pharmaceutical Industries Ltd. over its plans to introduce a generic version of attention deficit hyperactivity disorder drug Intuniv....To view the full article, register now.
Already a subscriber? Click here to view full article